skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,410  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Material Type:
Article
Add to My Research

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Nature (London), 2022-03, Vol.603 (7902), p.679-686 [Peer Reviewed Journal]

2022. The Author(s). ;Copyright Nature Publishing Group Mar 24, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04411-y ;PMID: 35042229

Full text available

2
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Material Type:
Article
Add to My Research

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Nature medicine, 2021-04, Vol.27 (4), p.620-621 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01270-4 ;PMID: 33558724

Full text available

3
Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
Material Type:
Article
Add to My Research

Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination

Clinical infectious diseases, 2021-12, Vol.73 (11), p.2065-2072 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab381 ;PMID: 33906236

Full text available

4
Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Material Type:
Article
Add to My Research

Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Nature immunology, 2020-11, Vol.21 (11), p.1336-1345 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-020-0782-6 ;PMID: 32887977

Full text available

5
Myocarditis With COVID-19 mRNA Vaccines
Material Type:
Article
Add to My Research

Myocarditis With COVID-19 mRNA Vaccines

Circulation (New York, N.Y.), 2021-08, Vol.144 (6), p.471-484 [Peer Reviewed Journal]

2021 American Heart Association, Inc. 2021 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056135 ;PMID: 34281357

Full text available

6
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
Material Type:
Article
Add to My Research

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

Cell host & microbe, 2021-05, Vol.29 (5), p.819-833.e7 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.03.005 ;PMID: 33789084

Full text available

7
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
Material Type:
Article
Add to My Research

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

The New England journal of medicine, 2021-01, Vol.384 (1), p.80-82 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2032195 ;PMID: 33270381

Full text available

8
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Material Type:
Article
Add to My Research

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Nature (London), 2022-03, Vol.603 (7901), p.488-492 [Peer Reviewed Journal]

2022. The Author(s). ;Copyright Nature Publishing Group Mar 17, 2022 ;The Author(s) 2022, corrected publication 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04460-3 ;PMID: 35102311

Full text available

9
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Material Type:
Article
Add to My Research

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Cell Host & Microbe, 2021-01, Vol.29 (1), p.44-57.e9 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2020.11.007 ;PMID: 33259788

Digital Resources/Online E-Resources

10
Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
Material Type:
Article
Add to My Research

Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2

Journal of clinical microbiology, 2020-05, Vol.58 (6) [Peer Reviewed Journal]

Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0095-1137 ;EISSN: 1098-660X ;DOI: 10.1128/jcm.00461-20 ;PMID: 32229605

Full text available

11
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Material Type:
Article
Add to My Research

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Cell reports (Cambridge), 2021-06, Vol.35 (13), p.109292-109292, Article 109292 [Peer Reviewed Journal]

2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2021.109292 ;PMID: 34166617

Full text available

12
Antibody evasion by the P.1 strain of SARS-CoV-2
Material Type:
Article
Add to My Research

Antibody evasion by the P.1 strain of SARS-CoV-2

Cell, 2021-05, Vol.184 (11), p.2939-2954.e9 [Peer Reviewed Journal]

2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.055 ;PMID: 33852911

Full text available

13
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Material Type:
Article
Add to My Research

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

New England Journal of Medicine, 2020-11, Vol.383 (20), p.1920-1931 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2022483 ;PMID: 32663912

Digital Resources/Online E-Resources

14
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Material Type:
Article
Add to My Research

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Cell, 2020-04, Vol.181 (2), p.281-292.e6 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.02.058 ;PMID: 32155444

Digital Resources/Online E-Resources

15
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Material Type:
Article
Add to My Research

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Nature (London), 2022-02, Vol.602 (7898), p.676-681 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04388-0 ;PMID: 35016198

Full text available

16
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Material Type:
Article
Add to My Research

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Nature (London), 2022-02, Vol.602 (7898), p.654-656 [Peer Reviewed Journal]

2021. The Author(s). ;Copyright Nature Publishing Group Feb 24, 2022 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04387-1 ;PMID: 35016196

Full text available

17
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Material Type:
Article
Add to My Research

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

The Lancet (British edition), 2021-02, Vol.397 (10275), p.671-681 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00234-8 ;PMID: 33545094

Full text available

18
Cell entry mechanisms of SARS-CoV-2
Material Type:
Article
Add to My Research

Cell entry mechanisms of SARS-CoV-2

Proceedings of the National Academy of Sciences - PNAS, 2020-05, Vol.117 (21), p.11727-11734 [Peer Reviewed Journal]

Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences May 26, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2003138117 ;PMID: 32376634

Full text available

19
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Material Type:
Article
Add to My Research

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Cell, 2021-04, Vol.184 (8), p.2201-2211.e7 [Peer Reviewed Journal]

2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021 The Authors 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.02.033 ;PMID: 33743891

Full text available

20
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants
Material Type:
Article
Add to My Research

Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants

Nature communications, 2021-11, Vol.12 (1), p.6977-6977, Article 6977 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-27325-1 ;PMID: 34848718

Full text available

Results 1 - 20 of 1,410  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,403)

Refine My Results

Creation Date 

From To
  1. Before 2014  (5)
  2. 2014 To 2015  (35)
  3. 2016 To 2017  (30)
  4. 2018 To 2020  (344)
  5. After 2020  (997)
  6. More options open sub menu

Language 

  1. English  (1,409)
  2. Japanese  (332)
  3. Chinese  (2)
  4. Norwegian  (2)
  5. French  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait